Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • eHealth applications in dermatology

Scoping review identifies barriers and facilitators

    • Congress Reports
    • Dermatology and venereology
    • Education
    • RX
    • Studies
  • 2 minute read

In the age of digitalization, the use of new technologies is also becoming increasingly important in dermatology. A team from the Institute for Health Services Research in Dermatology and the Nursing Professions at the University Medical Center Hamburg-Eppendorf has identified factors that can promote or hinder the use of such applications.

In the systematic literature search, the research team led by Prof. Dr. med. Matthias Augustin and Dr. med. Natalia Kirsten included evaluation studies on eHealth applications in dermatology as well as other literature sources such as surveys and interviews. Of 9349 hits in the PubMed database, 891 full texts were identified, from which a random sample of 60 publications was drawn. Relevant text passages were extracted and thematically categorized and evaluated using qualitative content analysis.

Pros and cons – findings of the secondary analysis at a glance

Factors explored as facilitators for the use of digital applications included: a high level of user-friendliness, secured funding, and compatibility with routine digital devices. The following aspects were identified as significant barriers: Mistrust of digital technologies, increased administrative effort, and the lack of integration into the practice software. Improved access to care, more detailed documentation of the disease, and reduced travel and waiting times were cited as expected positive effects. Potential negative effects feared included overuse of digital applications for financial reasons, an increase in unnecessary consultations, and triggered anxiety and confusion among patients. The authors suggest that the identified factors should be confirmed and discussed in further qualitative and quantitative studies. In the future development and implementation of digital applications for dermatology, the identified barriers and facilitators should be increasingly taken into account.

Source: Reinders P, et al: Scoping review on barriers and facilitators of eHealth applications in dermatology – A qualitative content analysis. Dermatologie kompakt und praxisnah 18-20.02.2022, abstract volume, P016.

 

DERMATOLOGIE PRAXIS 2022; 32(3): 38 (published 6/14/22, ahead of print).

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Augustin
  • Barriers
  • DDG compact and practical
  • Dermatology
  • digitization
  • eHealth
  • Facilitators
  • Kirsten
  • practice management
  • Reinders
  • Scoping Review
Previous Article
  • Hepatitis C therapy

Hepcare – a structured approach to successful treatment

  • Congress Reports
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • Infectiology
  • RX
View Post
Next Article
  • Neuroregeneration in multiple sclerosis

Involved cells and supporting drug identified

  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 10 min
  • Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

    • RX
    • CME continuing education
    • Pneumology
    • Studies
View Post
  • 6 min
  • Psoriasis and Obesity: Effects of Incretin-Based Therapies

Clinical trials shed light on the potential of semaglutide, liraglutide, and tirzepatide

    • Dermatology and venereology
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 7 min
  • Eosinophils in the Blood in COPD

How many measurements are needed to be sure?

    • RX
    • Education
    • General Internal Medicine
    • Pneumology
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal Pain – Von Meyenburg Complexes of the Liver

    • RX
    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • Surgery
View Post
  • 4 min
  • Multiple sclerosis

Physical and psychosocial fatigue have the greatest impact on HRQoL

    • RX
    • Education
    • Neurology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 8 min
  • Hyperhidrosis: Keep a Cool Head

An Overview of Important Treatment Options

    • RX
    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • This article was sponsored by Johnson & Johnson.

Give your patients a chance to live longer without progression with TECVAYLI® + DARZALEX® compared to DPd/DVd1

    • RX
    • Hematology
    • Oncology
    • Partner Content
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Idiopathic Pulmonary Fibrosis
  • 2
    Current status of PAT
  • 3
    Darier’s Disease, also known as Follicular Keratosis – Update 2026
  • 4
    An Enemy in the Microbiome?
  • 5
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.